Home › Funds › Humankind Investments LLC › EXEL

Humankind Investments LLC position in EXEL

EXELIXIS INC · Health Care

Humankind Investments LLC reported holding 26,500 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.62% of its reported portfolio and ranking #19 among its reported holdings. Humankind Investments LLC has disclosed EXEL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)26.50K sh
Reported value held$1.55M
Portfolio Weight0.62%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Humankind Investments LLC's EXEL position evolved

Humankind Investments LLC first disclosed a stake in EXEL in Q1 2026 at 26,500 shares (US$1.1M). The position peaked in Q3 2026 at 26,500 shares, worth US$1.5M. Across 3 filings, Humankind Investments LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 26,500 shares valued at US$1.5M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 26.50K $1.14M New
Q2 2026 26.50K $1.44M Hold
Q3 2026 26.50K $1.55M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 40 other funds we track also report a position in EXEL — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$858.3M), Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has Humankind Investments LLC held EXEL?

Humankind Investments LLC has disclosed EXEL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Humankind Investments LLC's current position in EXEL?

As of Q3 2026, Humankind Investments LLC holds 26.50K shares of EXEL (EXELIXIS INC), valued at $1.55M, representing 0.62% of its reported portfolio and ranking #19.

Has Humankind Investments LLC been buying or selling EXEL?

In the latest 13F filing (Q3 2026), Humankind Investments LLC held unchanged its position in EXEL. The position peaked in Q3 2026 at 26.50K shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, Farallon Capital Management, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.